Treace Medical Concepts Statistics
Total Valuation
TMCI has a market cap or net worth of $525.80 million. The enterprise value is $523.53 million.
Important Dates
The last earnings date was Thursday, February 27, 2025, after market close.
| Earnings Date | Feb 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TMCI has 62.60 million shares outstanding. The number of shares has increased by 2.07% in one year.
| Current Share Class | 62.60M |
| Shares Outstanding | 62.60M |
| Shares Change (YoY) | +2.07% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 24.28% |
| Owned by Institutions (%) | 49.87% |
| Float | 47.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.54 |
| Forward PS | 2.29 |
| PB Ratio | 4.73 |
| P/TBV Ratio | 5.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.62.
| Current Ratio | 4.62 |
| Quick Ratio | 3.35 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.59 |
Financial Efficiency
Return on equity (ROE) is -44.45% and return on invested capital (ROIC) is -17.80%.
| Return on Equity (ROE) | -44.45% |
| Return on Assets (ROA) | -14.83% |
| Return on Invested Capital (ROIC) | -17.80% |
| Return on Capital Employed (ROCE) | -30.54% |
| Revenue Per Employee | $438,904 |
| Profits Per Employee | -$116,862 |
| Employee Count | 477 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 1.20 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.37% in the last 52 weeks. The beta is 0.78, so TMCI's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -35.37% |
| 50-Day Moving Average | 8.98 |
| 200-Day Moving Average | 7.04 |
| Relative Strength Index (RSI) | 38.65 |
| Average Volume (20 Days) | 411,025 |
Short Selling Information
The latest short interest is 2.26 million, so 3.60% of the outstanding shares have been sold short.
| Short Interest | 2.26M |
| Short Previous Month | 2.23M |
| Short % of Shares Out | 3.60% |
| Short % of Float | 4.76% |
| Short Ratio (days to cover) | 5.15 |
Income Statement
In the last 12 months, TMCI had revenue of $209.36 million and -$55.74 million in losses. Loss per share was -$0.90.
| Revenue | 209.36M |
| Gross Profit | 168.26M |
| Operating Income | -55.64M |
| Pretax Income | -63.68M |
| Net Income | -55.74M |
| EBITDA | -48.22M |
| EBIT | -55.64M |
| Loss Per Share | -$0.90 |
Full Income StatementBalance Sheet
The company has $75.68 million in cash and $69.65 million in debt, giving a net cash position of $6.02 million or $0.10 per share.
| Cash & Cash Equivalents | 75.68M |
| Total Debt | 69.65M |
| Net Cash | 6.02M |
| Net Cash Per Share | $0.10 |
| Equity (Book Value) | 112.89M |
| Book Value Per Share | 1.81 |
| Working Capital | 126.48M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$37.17 million and capital expenditures -$11.59 million, giving a free cash flow of -$48.76 million.
| Operating Cash Flow | -37.17M |
| Capital Expenditures | -11.59M |
| Free Cash Flow | -48.76M |
| FCF Per Share | -$0.78 |
Full Cash Flow StatementMargins
Gross margin is 80.37%, with operating and profit margins of -26.57% and -26.63%.
| Gross Margin | 80.37% |
| Operating Margin | -26.57% |
| Pretax Margin | -26.63% |
| Profit Margin | -26.63% |
| EBITDA Margin | -23.03% |
| EBIT Margin | -26.57% |
| FCF Margin | n/a |
Dividends & Yields
TMCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.07% |
| Shareholder Yield | -2.07% |
| Earnings Yield | -10.53% |
| FCF Yield | -9.21% |
Analyst Forecast
The average price target for TMCI is $9.07, which is 7.98% higher than the current price. The consensus rating is "Hold".
| Price Target | $9.07 |
| Price Target Difference | 7.98% |
| Analyst Consensus | Hold |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMCI has an Altman Z-Score of 2.65 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.65 |
| Piotroski F-Score | 2 |